CHEMOTHERAPY OF RECURRENT MEDULLOBLASTOMA WITH COMBINED PROCARBAZINE, CCNU, AND VINCRISTINE

[1] BLOOM HJG, 1975, CANCER, V35, P111, DOI 10.1002/1097-0142(197501)35:1<111::AID-CNCR2820350116>3.0.CO

[2] 2-#

[3] BLOOM HJG, 1971, CRIT REV RADIOL SCI, V2, P89

[4] GUTIN PH, 1975, CANCER, V35, P1398, DOI 10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO

[5] 2-C

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[7] KUMAR ARV, 1974, J NEUROSURG, V40, P365

[8] LEVIN VA, 1978, CANCER CHEMOTH PHARM, V1, P41

[9] CRITERIA FOR EVALUATING PATIENTS UNDERGOING CHEMOTHERAPY FOR MALIGNANT BRAIN TUMORS [J]. JOURNAL OF NEUROSURGERY, 1977, 47 (03) : 329 - 335

[1] BLOOM HJG, 1975, CANCER, V35, P111, DOI 10.1002/1097-0142(197501)35:1<111::AID-CNCR2820350116>3.0.CO

[2] 2-#

[3] BLOOM HJG, 1971, CRIT REV RADIOL SCI, V2, P89

[4] GUTIN PH, 1975, CANCER, V35, P1398, DOI 10.1002/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO

[5] 2-C

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[7] KUMAR ARV, 1974, J NEUROSURG, V40, P365

[8] LEVIN VA, 1978, CANCER CHEMOTH PHARM, V1, P41

[9] CRITERIA FOR EVALUATING PATIENTS UNDERGOING CHEMOTHERAPY FOR MALIGNANT BRAIN TUMORS [J]. JOURNAL OF NEUROSURGERY, 1977, 47 (03) : 329 - 335